首页> 外国专利> BOVINE INTESTINAL MUCOSA ENOXAPARIN SODIUM, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF

BOVINE INTESTINAL MUCOSA ENOXAPARIN SODIUM, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF

机译:牛肠粘膜依诺肝素钠及其制备方法及其应用

摘要

Provided are bovine intestinal mucosa enoxaparin sodium, a preparation method therefor, and an application thereof. The bovine intestinal mucosa enoxaparin sodium is prepared from bovine intestinal mucosa heparin. Being different from enoxaparin sodium that derives from porcine intestinal mucosa heparin and is stipulated by pharmacopeias such as the USP 39 and the EP 8.6, the bovine intestinal mucosa enoxaparin sodium presents typical species and organ source (bovine intestinal mucosa) features. Also provided are two types of bovine intestinal mucosa enoxaparin sodium injections and preparation methods therefor, and applications in anticoagulation experiments inside animals. The bovine intestinal mucosa enoxaparin sodium has the halal property that is not owned by porcine enoxaparin sodium, thereby having great markets in wide Moslem population, countries, and regions. The bovine intestinal mucosa enoxaparin sodium and injections thereof can be applied to anticoagulant, anti-thrombus, anti-inflammatory, anticancer,and halal medicine.
机译:提供了牛肠粘膜依诺肝素钠,其制备方法及其应用。牛肠粘膜依诺肝素钠由牛肠粘膜肝素制备。牛肠粘膜依诺肝素钠不同于源自猪肠粘膜肝素的依诺肝素钠,它是由药典(例如USP 39和EP 8.6)规定的,具有典型的物种和器官来源(牛肠粘膜)特征。还提供了两种类型的牛肠粘膜依诺肝素钠注射剂及其制备方法,以及在动物体内的抗凝实验中的应用。牛肠粘膜依诺肝素钠的清真特性不属于猪依诺肝素钠,因此在回族人口,国家和地区都有广阔的市场。牛肠粘膜依诺肝素钠及其注射剂可用于抗凝,抗血栓,抗炎,抗癌和清真药。

著录项

  • 公开/公告号WO2017032276A1

    专利类型

  • 公开/公告日2017-03-02

    原文格式PDF

  • 申请/专利权人 SUZHOU RONNSI PHARMA CO. LTD.;

    申请/专利号WO2016CN96023

  • 发明设计人 JIN YONGSHENG;JIN CAIJUAN;YAO YIMING;

    申请日2016-08-19

  • 分类号C08B37/10;A61P7/02;

  • 国家 WO

  • 入库时间 2022-08-21 13:31:56

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号